BASF resumes A500 production; A1000 still on hold
Vitamin markets remain weak, with prices either declining or stable across most regions. Supply generally exceeds demand, and buyers are cautious, securing only part of their Q3 needs. Below is a brief update on key vitamins, including E 50%, A 1000, D3 500, D-Calpan, and B3.
In partnership with Feed Additive Prices
Vitamin E 50%
This week, most regions are experiencing a similar trend with a dip in prices. There has only been news from BASF concerning the restart of their vitamin A500 operation, but nothing yet about vitamin E. The market continues to show weakness and step-by-step price decline in all major regions. Buyers have managed to secure sufficient contracts for a portion of the third quarter, but they are adopting a wait-and-see attitude for longer-term contracts.
Vitamin A 1000
BASF announced some days ago that they will lift the Force Majeure on Vitamin A 500 https://nutrition.basf.com/global/en/Force-Majeure. No news around vitamin A 1000 yet. No significant response from the market so far, and the market trend continues to show a decline in prices across all major regions. Supply remains plentiful while demand appears restrained, and only a portion of Q3 is contracted.
Vitamin D3 500
Price levels are currently stable, although they are still relatively high. While there are sporadic signs of a slight decline, these do not indicate any substantial shifts. On the whole, prices remain at a high level, and availability continues to be limited in most areas. A large number of contracts for the third quarter have already been secured.
D-Calpan
The market remains largely stable yet somewhat subdued, with trading activity in many areas declining and prices staying low. An oversupply of material and available capacity appears to be exerting downward pressure on sales across all key regions. Currently, buyers are adopting a cautious strategy, having only secured a fraction of Q3.
Vitamin B3
The market remains largely stable with prices at lower levels, although some suppliers are eager to increase their volume by offering even more competitive prices; however, due to the well-saturated market, this does not result in significant sales. Buyers are taking a cautious approach at present, and only a portion of the third quarter has seen contracts finalised.
